These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28397450)

  • 1. Bethesda System in the evaluation of thyroid nodules: Review.
    Wesoła M; Jeleń M
    Adv Clin Exp Med; 2017; 26(1):177-182. PubMed ID: 28397450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
    Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
    Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.
    Crowe A; Linder A; Hameed O; Salih C; Roberson J; Gidley J; Eltoum IA
    Cancer Cytopathol; 2011 Oct; 119(5):315-21. PubMed ID: 21751427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation.
    Mastorakis E; Meristoudis C; Margari N; Pouliakis A; Leventakos K; Chroniaris N; Panayiotides I; Karakitsos P
    Cytopathology; 2014 Apr; 25(2):120-8. PubMed ID: 23551656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of ultrasound findings with the Bethesda cytopathology classification for thyroid nodule fine-needle aspiration: a primer for radiologists.
    Heller MT; Gilbert C; Ohori NP; Tublin ME
    AJR Am J Roentgenol; 2013 Sep; 201(3):W487-94. PubMed ID: 23971481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of fine needle aspiration cytology in pediatric thyroid nodules based on Bethesda Classification.
    Jiang W; Phillips SA; Newbury RO; Naheedy JH; Newfield RS
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):449-455. PubMed ID: 33629571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of ACR-Thyroid Imaging Reporting and Data system and The Bethesda System for Reporting Thyroid Cytopathology in the evaluation of thyroid nodules-An institutional experience.
    Sakthisankari S; Vidhyalakshmi S; Shanthakumari S; Devanand B; Nagul U
    Cytopathology; 2021 Jul; 32(4):472-481. PubMed ID: 33606346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bethesda System for Reporting Thyroid Cytopathology: A Retrospective Review of its Diagnostic Utility at Johns Hopkins Aramco Healthcare, Saudi Arabia.
    Alhashem MH; Alabidi A; Aly MG
    Am J Otolaryngol; 2021; 42(6):103088. PubMed ID: 34090018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
    Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
    Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
    Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
    Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis.
    Vuong HG; Ngo HTT; Bychkov A; Jung CK; Vu TH; Lu KB; Kakudo K; Kondo T
    Cancer Cytopathol; 2020 Apr; 128(4):238-249. PubMed ID: 31883438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study between conventional and the Bethesda System for Reporting Thyroid Cytology of 240 cases.
    Pandey P; Dixit A; Sawhney A; Ralli M; Chaturvedi V; Agarwal S; Singh JP; Gupta S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S253-S258. PubMed ID: 36510973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A correlative study of solitary thyroid nodules using the bethesda system for reporting thyroid cytopathology.
    Arul P; Masilamani S
    J Cancer Res Ther; 2015; 11(3):617-22. PubMed ID: 26458591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of diagnostic performance of pathologists by reducing the number of pathologists responsible for thyroid fine needle aspiration cytology: An institutional experience.
    Seok JY; An J; Cho HY
    Diagn Cytopathol; 2018 Jul; 46(7):561-567. PubMed ID: 29356393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
    Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting thyroid nodule malignancy at several prevalence values with a combined Bethesda-molecular test.
    Lasolle H; Riche B; Decaussin-Petrucci M; Dantony E; Lapras V; Cornu C; Lachuer J; Peix JL; Lifante JC; Capraru OM; Selmi-Ruby S; Rousset B; Borson-Chazot F; Roy P
    Transl Res; 2017 Oct; 188():58-66.e1. PubMed ID: 28797549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
    Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
    Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) - An 8-year tertiary center experience in Thailand.
    Thewjitcharoen Y; Butadej S; Nakasatien S; Chotwanvirat P; Porramatikul S; Krittiyawong S; Lekpittaya N; Himathongkam T
    J Clin Transl Endocrinol; 2019 Jun; 16():100175. PubMed ID: 30815363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
    Lew JI; Snyder RA; Sanchez YM; Solorzano CC
    J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.